BDNF levels have been reported to be decreased in the brains of patients with major depressive disorder, bipolar disorder, schizophrenia, Alzheimer’s disease, and Parkinson’s disease [2]. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.